Association of Prior BNT162b2 COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection in Children and Adolescents During Omicron Predominance-Reference-Cited by-同舟云学术

Association of Prior BNT162b2 COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection in Children and Adolescents During Omicron Predominance

Published:2022-06-14 Issue:22 Volume:327 Page:2210
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Fleming-Dutra Katherine E.¹,Britton Amadea¹²,Shang Nong¹,Derado Gordana¹,Link-Gelles Ruth¹,Accorsi Emma K.¹²,Smith Zachary R.¹,Miller Joseph¹,Verani Jennifer R.¹,Schrag Stephanie J.¹

Affiliation:

1. US Centers for Disease Control and Prevention COVID-19 Response, Atlanta, Georgia

2. Epidemic Intelligence Service, US Centers for Disease Control and Prevention, Atlanta, Georgia

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jama/articlepdf/2792524/jama_flemingdutra_2022_oi_220049_1654637408.83177.pdf

Reference28 articles.

1. Hospitalizations of children and adolescents with laboratory-confirmed COVID-19: COVID-NET, 14 states, July 2021-January 2022.;Marks;MMWR Morb Mortal Wkly Rep,2022

2. Evaluation of the BNT162b2 COVID-19 vaccine in children 5 to 11 years of age.;Walter;N Engl J Med,2022

3. Safety, immunogenicity, and efficacy of the BNT162b2 COVID-19 vaccine in adolescents.;Frenck;N Engl J Med,2021

4. Association of COVID-19 vaccination with symptomatic SARS-CoV-2 infection by time since vaccination and Delta variant predominance.;Britton;JAMA,2022

5. Association between 3 doses of mRNA COVID-19 vaccine and symptomatic infection caused by the SARS-CoV-2 Omicron and Delta variants.;Accorsi;JAMA,2022

Cited by 128 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk benefit analysis to evaluate risk of thromboembolic events after mRNA COVID-19 vaccination and COVID-19;npj Vaccines;2024-09-13

2. Evaluating the impact of extended dosing intervals on mRNA COVID-19 vaccine effectiveness in adolescents;BMC Medicine;2024-09-12

3. T cell hybrid immunity against SARS-CoV-2 in children: a longitudinal study;eBioMedicine;2024-07

4. Evaluating the impact of extended dosing intervals on mRNA COVID-19 vaccine effectiveness in adolescents;2024-06-18

5. Risk of Blood Clots After COVID-19 Vaccination and Infection: A Risk-Benefit Analysis;2024-06-07